Read Larry Connors' blog – Short Term Trading Strategies
The new website is designed so every woman can access the dermo-basics: science made simple, concise information on the advanced ingredients, and easy access to an ongoing skin care dialogue.
"We want the Striking website and social community to be an informative and entertaining resource for the latest in skin health and beauty trends," said Robin Carmichael, Vice President of Marketing & Business Development. "The web boutique offers the high performance and elegant Striking Skin Care line formulated with SmartPeptide technology that specifically targets the needs of skin ravaged by transitioning hormones. Striking picks up where a woman's previous basic skin care starts to wear down in performance and reinvents new vitality and radiance."
About The Website
The vibrant and spa-like website provides an easy to navigate online environment where visitors can learn more about the products, ingredients, and brand at the click of a button.
The site includes enhanced features such as an ongoing video series as well as an engaging social community supported by Twitter, Facebook, YouTube, the Striking Blog and the Simply Striking(TM) monthly newsletter.
About The Products
With over 45 million menopausal and post-menopausal women in the US, Helix BioMedix recognized the need for skin care formulated for the needs of hormonally aging skin. The dermatologist tested Striking anti-aging cosmeceutical line was developed with an emphasis on skin health and proven efficacy.
Helix BioMedix SmartPeptide(TM) technology is the core of Striking Skin Care's moisturizer, eye and serum products that help with common aging concerns such as loss of firmness, fine lines and wrinkles and dry, damaged skin. The Striking Skin Care line works synergistically to restore a radiant appearance. Every drop of Striking Skin Care products deliver the latest dermatologist tested formulations to help support and refine the skin.
Affordably priced, the skin care collection includes:
Striking Multi-Peptide Serum 1.13oz SRP $65
Striking Rejuvenating Eye Creme 0.5oz SRP $35
Striking Restorative Moisture Creme 1oz SRP $42
Striking Multi-Vitamin Creme Cleanser 8oz SRP $28
About The Technology
Only Helix BioMedix holds the patents to SmartPeptide technology. The next generation in scientifically advanced ingredients, SmartPeptide molecules are targeted to address changes in the appearance of skin associated with the aging process by mimicking specific amino acid chains that support the body's own defend and protect systems. In a recent clinical study, 84% of Striking Multi-peptide Serum users said they saw a reduction in fine lines and wrinkles after just 14 days of use. Additionally, unlike many other products on the market, Striking Skin Care products are free of parabens, fragrance, artificial colors, pore-clogging ingredients and formaldehyde-releasing ingredients.
About Helix BioMedix, Inc.
Helix BioMedix, Inc. is a biopharmaceutical company with an extensive library of diverse bioactive peptides and patents covering six distinct classes and hundreds of thousands of peptide sequences. Core competencies include peptide design, synthesis and characterization together with assay development, screening, tissue culture and microbiology, leveraged through relationships with contract research organizations and peptide manufacturers. The company takes product development programs from theoretical concept to a validated and qualified skin care active ingredient fully validated as to efficacy and safety. Applications for Helix BioMedix peptides include anti-aging cosmeceutical skin care and acne treatment as well as other topical anti-infective pharmaceuticals and wound healing applications. Striking and SmartPeptide are trademarks of Helix BioMedix, Inc. More information about the company and its proprietary peptides may be found on the company's website at www.helixbiomedix.com.
SOURCE: Helix BioMedix
Media For Helix BioMedix Katie B. Wilkinson, 425-220-1125 kpublicrelations.com katie@kpublicrelations.com or Company Contact: Helix BioMedix, Inc Robin L. Carmichael, 425-402-8400 Vice President of Marketing & Business Development rcarmichael@helixbiomedix.com or Investor Relations & Financial Media: Shelton Group Investor Relations Matt Kreps, 972-239-5119 X 125 mkreps@sheltongroup.com
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.
